U2AF1 mutations (MT) are typically acquired later in life and associated with rapid rates of progression to MDS and AML [12–17] U2AF1 MT predominantly occur at two hotspots (S34F, Q157) located in zinc finger regions [5]. Here, U2AF1 is linked to acute myeloid leukemia.